Key Segmentation
By Modality
-
SPECT
-
PET-CT
-
PET
-
MRI
-
Others
By Application
-
Oncology
-
Neurology
-
Cardiology
-
Others
By Product
-
Systems/Equipment
-
Radiopharmaceuticals
-
Software
By End User
-
Hospitals
-
Research Institutes
-
Diagnostic Centres
-
Others
Regional Coverage:
North America
-
United States
-
Canada
Europe
-
Germany
-
United Kingdom
-
France
-
Italy
-
Spain
-
Russia
-
Poland
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Australia
-
ASEAN Countries
-
Rest of Asia Pacific
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Mexico
-
Colombia
-
Rest of Latin America
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market players
Frequently Asked Questions
The Molecular Imaging Market is expected to grow at a CAGR of 4.5% from 2026 to 2035.
The Molecular Imaging Market was valued at USD 9.25 Billion in 2025.
Rising global cancer and neurological disease incidence creating clinical imaging demand, novel radiopharmaceutical approvals expanding the addressable molecular imaging market into new disease categories, and theranostics programme growth creating combined diagnostic and therapeutic procurement that sustains above-average clinical imaging volume.
SPECT dominated the Molecular Imaging Market with 42% share in 2025, while PET-CT is the fastest growing modality.
North America dominated the Molecular Imaging Market in 2025, with the United States accounting for approximately 76% of North American revenues.